Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 18
Dermoscopic Features of Erosive Pustular Dermatosis of the Scalp: A Comparative Multicentric Retrospective Study in Bald and Hairy Patients
Authors Plozner N , Zelin E, Zalaudek I, Lallas A, Piraccini BM, Starace M, Errichetti E
Received 3 January 2025
Accepted for publication 19 March 2025
Published 20 March 2025 Volume 2025:18 Pages 669—676
DOI https://doi.org/10.2147/CCID.S514416
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Noemi Plozner,1 Enrico Zelin,1 Iris Zalaudek,2 Aimilios Lallas,3 Bianca Maria Piraccini,4,5 Michela Starace,4,5 Enzo Errichetti1
1Institute of Dermatology, Department of Medical Area, University of Udine, Udine, Italy; 2Department of Dermatology, ‘Maggiore’ Hospital, University of Trieste, Trieste, Italy; 3First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, GR-54124, Greece; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
Correspondence: Noemi Plozner, Institute of Dermatology, Department of Medicine, University of Udine, Piazzale Santa Maria della Misericordia, 15, Udine, 33100, Italy, Tel +39 0432559822, Email [email protected]
Background: Erosive pustular dermatosis of the scalp (EPDS) is a rare inflammatory disorder primarily affecting elderly individuals with bald or hairy scalps. It is often misdiagnosed due to clinical overlap with other scalp conditions. Dermoscopy is an invaluable diagnostic tool for hair and scalp disorders, but its utility in EPDS remains underexplored. This study aims to identify dermoscopic features of EPDS and compare them with differential diagnoses to improve non-invasive recognition.
Materials and Methods: A retrospective multicentric study was conducted across three Italian dermatological centers. Two cohorts, bald and hairy patients with histologically confirmed EPDS, were compared with controls diagnosed with conditions mimicking EPDS. Dermoscopic images at 10× magnification were analyzed by two independent evaluators using standardized criteria. Comparative analyses of dermoscopic features and interobserver agreement were performed, with statistical significance set at p< 0.01.
Results: A total of 116 patients [53 bald patients (28 with EPDS and 25 controls) and 63 hairy patients (32 with EPDS and 31 controls)] were included in the study. Among EPDS bald patients, linear-curved vessels (unspecific distribution) (78.6%), orange structureless areas (diffuse) (46.4%), and yellow scales/crusts (focal) were the main findings, whereas focal yellow scales/crusts (84.4%) and the “peripheral horizontal hair” sign (84.4%) turned out to be the most common features in EPDS hairy patients. Comparative analysis revealed linear-curved vessels (p< 0.001), orange structureless areas (diffuse) (p< 0.001) and non-follicular pustules (p=0.005) to be distinctive features of EPDS in bald patients, while yellow scales/crusts (focal), non-follicular pustules and “peripheral horizontal hair” sign (horizontally arranged hair whose proximal part of the shaft is seen through a thinned epidermis at the edge of alopecic areas) were related (p< 0.001) to EPDS in hairy patients. Interobserver agreement was excellent (Kappa=0.81– 0.83).
Conclusion: Dermoscopy provides valuable diagnostic clues for EPDS, distinguishing it from other scalp disorders.
Keywords: alopecias, dermoscopy, diagnosis, differential diagnosis, hair disorders
Introduction
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon inflammatory disorder affecting the scalp and typified by patches of hair loss along with erosions, thick yellow or yellow-brown crusts, superficial ulcers, and pustules. It progresses over months or years, eventually resulting in skin atrophy and scarring alopecia. Elderly individuals with a bald, sun-damaged scalp represent the most common involved population, yet instances affecting hairy subjects may also be seen.1 EPDS can be difficult to diagnose, particularly in its early stages when the clinical presentation overlaps with other scalp disorders, such as scalp infections, bullous diseases, and cicatricial alopecias.1 In this regard, dermoscopy has been proven to be a valuable diagnostic tool in assisting the recognition of various hair and scalp disorders by revealing specific clues, thus decreasing the number of cases needing biopsy.2 However, data on dermoscopic features of EPDS is limited.3,4
The aim of the present retrospective observational multicentric study was to compare the dermoscopic findings of EPDS in bald and hairy patients with those of the main differential diagnoses in order to improve the non-invasive recognition of such a condition.
Materials and Methods
This was a multicentric observational retrospective analysis involving three dermatological centers from Italy (Udine, Bologna and Trieste). The study population consisted of two cohorts, ie, consecutive bald (I) and hairy (II) patients diagnosed with EPDS according to histological assessment; controls were also considered by selecting subjects (bald and hairy) with hair disorders for which EPDS was included into the clinical differential diagnosis. We included only cases where high-quality dermoscopic images of the affected area were available, specifically the region from which the biopsy sample was taken or the most clinically representative lesion. Images were captured at 10× magnification under polarized light in a dry setting, with the possible additional use of a fluid interface based on the physician’s evaluation.
Histologically confirmed diagnosis of Erosive Pustular Dermatosis of the Scalp (EPDS) was needed for the enrollment. To ensure that treatment-related changes did not influence the findings, they must not have undergone systemic or topical treatment for scalp conditions in the three months preceding the dermoscopic evaluation. Additionally, complete clinical and demographic data, including age, sex, and medical history, had to be accessible. Only patients from one of the three participating dermatology centers—Udine, Bologna, or Trieste—who met all these criteria were included. Patients were excluded from the study if histopathological confirmation of EPDS was unavailable or if the dermoscopic images were of insufficient quality due to low resolution, poor focus, or non-standardized lighting conditions that could interfere with interpretation. Those who had used systemic or topical therapies, such as corticosteroids or immunosuppressants, within three months before the dermoscopic assessment were also excluded, as these treatments could alter the appearance of the skin and hair. Moreover, patients with coexisting scalp diseases, including autoimmune disorders like discoid lupus erythematosus or lichen planopilaris, as well as chronic infections affecting the scalp, were not considered eligible. Lastly, insufficient clinical data or incomplete patient records resulted in exclusion from the study.
Dermoscopic images were randomly evaluated by two independent experienced investigators (E.E. and N.P.), who assessed dermoscopic findings according to the International Dermoscopy Society criteria for non-neoplastic dermatoses5 integrated with parameters proposed by Rudnicka et al for follicular findings.6 Each feature was recorded and analyzed based on its prevalence in both EPDS and control groups. Comparative analyses were also performed separately for bald and hairy patient groups to assess any differences in dermoscopic features with controls. Interobserver agreement for EPDS cohorts was evaluated through Cohen’s kappa coefficient, whereas Fisher’s exact test with p-value set at 0.01 was used for comparative analyses. All statistical calculations were performed using Microsoft Excel, ensuring systematic data handling and accurate computation of values. Total duration of data collection was 6 months (January-June 2024).
Results
A total of 116 patients [53 bald patients (28 with EPDS and 25 controls) and 63 hairy patients (32 with EPDS and 31 controls)] were included in the study; mean age was 68 and 57 years for bald and hairy EPDS cases and 61 and 59 years for corresponding controls, respectively. In the control groups we included: 16 squamous cell carcinomas, six pemphigus vulgaris and three cicatricial pemphigoid (bald patients); 14 folliculitis decalvans, 11 discoid lupus erythematosus, five lichen planopilaris and two pityriasis amiantacea (hairy patients). For all instances, hand-held dermatoscope Dermlite DL5 (San Juan Capistrano, CA, United States) coupled with a high resolution camera or smartphone was employed.
Considering bald patients (Figure 1 and Table 1), the main dermoscopic features (prevalence greater than one-third) of EPDS turned out to be linear-curved vessels (unspecific distribution) (78.6%), orange structureless areas (diffuse) (46.4%), and yellow scales/crusts (focal) (39.3%); other relevant findings included white structureless areas (focal) (32.1%), non-follicular pustules (28.6%), and dotted, linear and linear with branches vessels (28.6–32.1%). Moving to hairy patients with EPDS (Figure 2 and Table 2), yellow scales/crusts (focal) and horizontally arranged hairs with the proximal part of the shaft being visible through a thinned epidermis at the edge of alopecic areas (“peripheral horizontal hair” sign) were the main dermoscopic features (both with a prevalence of 84.4%). Further common findings included linear vessels and linear vessels with branches (unspecific distribution) (56.3% and 40.6%, respectively), white structureless areas (focal) (53.1%), non-follicular pustules (40.6%), broken hairs (40.6%), and black dots (34.4%).
![]() |
Table 1 Dermoscopic Findings of Included Instances of Erosive Pustular Dermatosis of the Scalp (EPDS) and Controls in Bald Patients, Along With Results of the Comparative Analysis |
![]() |
Table 2 Dermoscopic Findings of Included Instances of Erosive Pustular Dermatosis of the Scalp (EPDS) and Controls in Hairy Patients, Along With Results of the Comparative Analysis |
Turning to the comparative analyses, we found the following findings to be statistically more common in EPDS compared to controls in bald patients (Table 1): linear-curved vessels (p<0.001), orange structureless areas (diffuse) (p<0.001), and non-follicular pustules (p=0.005). Notably, this last feature was more frequent in EPDS affecting hairy patients compared to controls (p<0.001), along with yellow scales/crusts (focal), and “peripheral horizontal hair” sign (p<0.001 for both of them). On the other hand, perifollicular white scales (p=0.003) and follicular plugs (p<0.001) were more common in the control group. For further analytical details see Table 2.
In terms of inter-observer concordance about dermoscopic findings in EPDS, we found significant agreement between evaluators, with Kappa values being 0.81 and 0.83 for bald and hairy cohorts, respectively.
Discussion
Our study underlines that dermoscopy may be of help in assisting the recognition of EPDS in both bald and hairy patients. In particular, the diagnostic clues in the former population included linear-curved vessels, orange structureless areas (diffuse), and non-follicular pustules. The first two features were already reported as common findings in bald patients with EPDS histologically typified by lymphoplasmacellular infiltrate in a small case-series published by some of the authors of this study.4 Interestingly, orange structureless areas were thought to be related to either a compact cellular infiltrate in the dermis (“mass effect”) or dermal hemosiderin deposits.5,7 Of note, similarly to Zoon’s balanitis, the presence of linear-curved vessels has been described as a possible dermoscopic clue of lymphoplasmacellular EPDS in bald population, in line with our results.4 This association is explained by the histological background as EPDS is characterized by atrophic epidermis, thus allowing the visualization of enlarged dermal vessels.3,7 Importantly, in our study we did not perform a dermoscopic-pathological correlation analysis, thereby preventing us to establish a possible correlation between the aforementioned dermoscopic findings and the type of cellular infiltrate.
More recently, Gupta et al described a rare case of Erlotinib-induced EPDS, highlighting trichoscopic findings that further expand the spectrum of EPDS presentations.8 While our study focuses on spontaneous EPDS cases, the inclusion of drug-induced variants in future analyses may provide a broader understanding of its dermoscopic variations and pathophysiological mechanisms. These insights emphasize the need for further prospective studies, particularly integrating trichoscopy with histopathological correlation, to refine diagnostic accuracy and guide clinical management.
Another relevant feature emerging from our study was the association between non-follicular pustules resulting from the neutrophilic infiltration of the epidermis/upper dermis and EPDS in both bald and hairy patients. Besides such a dermoscopic clue, other typical findings of EPDS found in our hairy population included non-follicular focal yellow scales/crusts due to the drying of pustules as well as the presence of horizontally arranged hairs with proximal part of the shaft being visible through a thinned epidermis at the edge of alopecic areas (“peripheral horizontal hair” sign). According to our comparative analysis, the latter clue is indicative of EPDS in hairy patients as it was not seen in the main differential diagnoses. This is consistent with a case-series including 20 instances reported by some of the authors of the present analysis that found bulbs of the hair follicles visible through the thinned skin to be one of the most common dermoscopic findings of EPDS in hairy subjects.3 From a dermoscopic-pathological correlation point of view, it is possible that “peripheral horizontal hair” sign is due to the remarkable dermal fibrosis typical of EPDS that may give rise to displacement of the hair roots towards the atrophic skin surface at the periphery of the alopecic patches.3,7 Notably, unlike our analysis, perifollicular yellow crusts turned out to be the most frequent scaling/crusting pattern in the previous study.3 Additionally, we also observed non-follicular pustules to be another distinctive feature of EPDS, while they were not reported in the prior analysis. It is likely that such differences might be due to the selection of lesions in different stages of development.
Limitations
The main limitations of the study include (I) the retrospective design, which is prone to recall and observation biases, that were addressed by involving evaluators who did not contribute to the sample collection; (II) the lack of dermoscopic-pathological correlation analysis; and (III) the potential variability introduced by having multiple investigators collecting the images at different centers, yet the use of the same dermoscopic device reduced the relevance of such a bias. Therefore, future studies addressing such points are needed to confirm our preliminary data.
Conclusions
This study highlights the diagnostic value of dermoscopy in EPDS, providing distinctive dermoscopic features that help differentiate EPDS from other scalp conditions. In bald patients, the most characteristic findings included linear-curved vessels, diffuse orange structureless areas, and non-follicular pustules. In hairy patients, EPDS was associated with focal yellow scales/crusts, non-follicular pustules, and the “peripheral horizontal hair” sign. The identification of these dermoscopic clues may assist dermatologists in reducing diagnostic uncertainty and potentially decreasing the need for invasive biopsies in suspected cases of EPDS.
Data Sharing Statement
All the data of the study is included in the present manuscript.
Compliance with Ethics Guidelines
The patients in this manuscript provided informed consent for the publication of case details, and institutional approval was not required, as the study was based on data retrospectively collected in a routine clinical setting, consistently with AIFA (Italian Medicines Agency) regulation (AIFA Determination, March 20, 2008). This study complies with the Declaration of Helsinki and no ethical approval was required as it results from clinical routinary activity. Accessed data for the study complied with relevant data protection and privacy regulations.
Consent to Publication Form
Consent to publication form has been signed by the patients included in this study.
Author Contributions
All authors made a significant contribution to the work reported (ie, conception, study design, execution, acquisition of data, analysis, and interpretation); took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Michela Starace and Enzo Errichetti are qualified as last author.
Funding
No funding or sponsorship was received for this study or publication of this article.
Disclosure
Professor Iris Zalaudek reports personal fees from Sunpharma, personal fees from Sanofi, personal fees from La Roche Posay, personal fees from Philogen, outside the submitted work. The authors report no other conflicts of interest in this work.
References
1. Starace M, Alessandrini A, Baraldi C, Piraccini BM. Erosive pustular dermatosis of the scalp: challenges and solutions. Clin Cosmet Invest Dermatol. 2019;12:691–698. doi:10.2147/CCID.S205499
2. Errichetti E. Dermoscopy of inflammatory dermatoses (inflammoscopy): an up-to-date overview. Dermatol Pract Concept. 2019;9(3):169–180. doi:10.5826/dpc.0903a01
3. Starace M, Loi C, Bruni F, et al. Erosive pustular dermatosis of the scalp: clinical, trichoscopic, and histopathologic features of 20 cases. J Am Acad Dermatol. 2017;76(6):1109–1114.e2. doi:10.1016/j.jaad.2016.12.016
4. Zelin E, Conforti C, Toffoli L, Di Meo N, Signoretto D, Zalaudek I. Dermoscopy of lymphoplasmacellular erosive dermatitis of the scalp reveals striking similarities to lymphoplasmacellular balanitis of Zoon. Dermatol Pract Concept. 2022;12(4):e2022198. doi:10.5826/dpc.1204a198
5. Errichetti E, Zalaudek I, Kittler H, et al. Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non-neoplastic dermatoses): an expert consensus on behalf of the International Dermoscopy Society. Br J Dermatol. 2020;182(2):454–467. doi:10.1111/bjd.18125
6. Rudnicka L, Olszewska M, Rakowska A, Kowalska-Olędzka E. Atlas of Trichoscopy: Dermoscopy in Hair and Scalp Disease. Berlin, Germany: Springer-Verlag; 2012.
7. Wilk M, Zelger BG, Hauser U, Höpfl R, Zelger B. Erosive pustular dermatosis of the scalp: reappraisal of an underrecognized entity. J Dtsch Dermatol Ges. 2018;16(1):15–19. doi:10.1111/ddg.13387
8. Gupta S, Chopra D, Preeyati. Erosive pustular dermatosis of the scalp secondary to Erlotinib: a rare occurrence with trichoscopic perspective. J R Coll Physicians Edinb. 2023;53(4):255–257. doi:10.1177/14782715231196606
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

Dermoscopy of Primary Localized Cutaneous Nodular Amyloidosis
Pulgarin LM, De Pellegrin A, Stinco G, Errichetti E
Clinical, Cosmetic and Investigational Dermatology 2024, 17:395-398
Published Date: 8 February 2024
Case Study: Rosai-Dorfman Disease and Its Multifaceted Aspects
Werneck Rodrigues DO, Wolp Diniz R, Dentz LC, Costa MA, Lopes RH, Suassuna LF, Cintra JRD, Domenge C
Journal of Blood Medicine 2024, 15:123-128
Published Date: 11 March 2024
Analysis and Perception of Chlamydia psittaci Pneumonia: Novel Insights of the Rare Disease in Infectiology
Huang H, Liu Y, Liu Y, Lin J, Guo H, Xu Q, Zhang H, Li Z, Zhu H, Ding M
Infection and Drug Resistance 2024, 17:5261-5275
Published Date: 28 November 2024
Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting
Bruno GM, Di Matteo S, Longo C, Stanganelli I, Farnetani F, Borsari S, Mazzoni L, Ciardo S, Raucci M, Magi S, Bassoli S, Spadafora M, Mandel VD, Casari A, Chester J, Kaleci S, Colombo GL, Pellacani G
Risk Management and Healthcare Policy 2025, 18:163-172
Published Date: 15 January 2025